Butterfly SPAC Presentation Deck slide image

Butterfly SPAC Presentation Deck

Investment Case Summary A unique investment in a dynamic Med-Tech environment Our investment case is clear: Butterfly attacks a large, $8 billion addressable market and expands it materially by meaningfully growing each of the following: points of care, geographic reach and use cases Butterfly has a very clear right to win. Butterfly is the best product, the best price, and the best platform Butterfly has many attractive investment attributes: strong balance sheet and liquidity, low manufacturing costs, rapid growth, high recurring revenue, a discounted relative valuation and high-return reinvestment opportunities ● ● ● ● Finally, Butterfly has strong alignment, building clinical and societal value designed for commercial success and shareholder value creation 9
View entire presentation